## Abstract ## Objective To determine serum levels of BAFF, a potent B cell survival factor, in patients with systemic sclerosis (SSc) and relate the results to the clinical features of SSc. ## Methods Serum BAFF levels in 83 patients with SSc were examined by enzyme‐linked immunosorbent assay (
✦ LIBER ✦
Elevated serum B lymphocyte stimulator levels in patients with systemic immune–based rheumatic diseases
✍ Scribed by Gurtej S. Cheema; Viktor Roschke; David M. Hilbert; William Stohl
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 83 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Elevated serum BAFF levels in patients w
✍
Takashi Matsushita; Minoru Hasegawa; Koichi Yanaba; Masanari Kodera; Kazuhiko Ta
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 167 KB
B lymphocyte stimulator levels in system
✍
Lauren L. Ritterhouse; Sherry R. Crowe; Timothy B. Niewold; Joan T. Merrill; Vir
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 240 KB
👁 1 views
Objective. To examine the relationship between circulating B lymphocyte stimulator (BLyS) levels and humoral responses to influenza vaccination in systemic lupus erythematosus (SLE) patients, as well as the effect of vaccination on BLyS levels, and to investigate clinical and serologic features of S
Elevated serum levels of soluble CD44 ca
✍
Stefano Molica; Gaetano Vitelli; Domenico Levato; Diana Giannarelli; Giuseppe Ma
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 113 KB
👁 2 views